Gilead Sciences
GILD
GILD
1,710 hedge funds and large institutions have $76B invested in Gilead Sciences in 2024 Q1 according to their latest regulatory filings, with 138 funds opening new positions, 634 increasing their positions, 728 reducing their positions, and 169 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 634 | Existing positions reduced: 728
18% less first-time investments, than exits
New positions opened: 138 | Existing positions closed: 169
39% less funds holding in top 10
Funds holding in top 10: 23 → 14 (-9)
Holders
1,710
Holding in Top 10
14
Calls
$728M
Puts
$684M
Top Buyers
| 1 | +$360M | |
| 2 | +$286M | |
| 3 | +$257M | |
| 4 |
Two Sigma Investments
New York
|
+$233M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$213M |
Top Sellers
| 1 | -$1.29B | |
| 2 | -$771M | |
| 3 | -$337M | |
| 4 |
Goldman Sachs
New York
|
-$326M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$257M |